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To the Editor: Tain and Baylis1 recently reported on a
dimethylarginine dimethylaminohydrolase (DDAH) activity
assay for kidney homogenate. Using this assay, which is a
modification of the Prescott–Jones colorimetric assay,2 Tain
and Baylis1 found that nitrite, the nitric oxide (NO) donor
diethylamine NONOate and the superoxide forming agent
2,3-dimethoxy-1,4-naphthoquinone inhibited (at 0.1 and
1 mM) cortical DDAH activity in vitro.1 In our opinion, this
work does not provide evidence of DDAH sensitivity to NO
and oxidative stress because of methodological problems
which we would like to discuss here.
The inhibition of DDAH activity by nitrite1 is very
surprising. A possible explanation for the apparent inhibitory
effect of nitrite and diethylamine NONOate could be
interference by these species and nitrate in the DDAH assay,
for example at the derivatization step. Indeed, Prescott and
Jones2 reported that nitrate inhibited color development in
their assay. We are unaware of interference studies by the
substances tested in the paper by Tain and Baylis.1 That
diethylamine NONOate was less effective than nitrite,1 argues
against a sensitivity of DDAH activity to nitrosative stress. In
addition, inhibition of DDAH activity seen by nitrite and the
NO donor diethylamine NONOate1 could have resulted from
artifactual S-nitrosation of DDAH SH-groups by nitrous acid
(pKa 3.4). Using a fully validated and interference-free gas
chromatography–mass spectrometry assay,3 we found no
inhibition of DDAH activity by nitrite or nitrate in vivo in
humans3 and in vitro (Figure 1).
Like N-ethylmaleimide,4 2,3-dimethoxy-1,4-naphthoqui-
none is a potent SH-groups alkylating agent. The inhibitory
effect of 2,3-dimethoxy-1,4-naphthoquinone on DDAH
activity1 could have resulted from the ability of 2,3-
dimethoxy-1,4-naphthoquinone to alkylate rather than to
oxidize SH-groups of DDAH.
Albeit generally accepted, there is no solid evidence of
the sensitivity of DDAH to nitrosative and oxidative stress
in vitro and in vivo. Investigations addressing this issue
should: (1) avoid potential methodological pitfalls; (2)
involve use of specific superoxide-producing agents or
enzymes; and (3) last but not least important, involve use
of drugs at (patho)physiologically or pharmacologically
relevant concentrations.
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We have the following responses to the comments made by
Dr Chobanyan and Dr Tsikas, regarding the quality of our
recent publication ‘Determination of dimethylarginine
dimethylaminohydrolase [DDAH] activity in the kidney’.1
Nitrite is a source of nitric oxide synthase-independent
nitric oxide production under hypoxic and normoxic
conditions2,3 and that was the reason we used nitrite in
these studies. Regarding possible background effects of
nitrite (and any other agent that we used), every reagent in
our assay was run with a corresponding blank (that is
asymmetric dimethylarginine (ADMA) omitted) see sup-
plement, published online.1 Neither nitrite nor diethyl-
amine NONOate had any effect on the blank value,
demonstrating that the decrease of color formation by
nitrite is not due to interference. The lack of an effect of
nitric oxide on DDAH activity in the study by Tsikas and
co-workers4 may be related to their use of a different tissue
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Figure 1 | Effect of sodium nitrite and nitrate on DDAH activity
in vitro in rat liver homogenate (0.1 M phosphate buffer, pH
7.2). DDAH activity was determined by measuring dimethylamine
(DMA) formation from ADMA (100 mM) by GC–MS.3 Data are
presented as mean±standard deviation from triplicate
incubations. DDAH activity of 100% corresponds to
17.8±1.7 pmol DMA per minmg protein. Nitrite and nitrate
(0–1 mM) did not interfere with the GC–MS measurement of DMA
in rat liver homogenate in the absence of ADMA (data not shown).
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